GlassScriptPhysician profile
Clement S Qaqish
NPI 1588830707
$5,984.47
in general payments reported to CMS, 2019-2025
13 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $3,656 · 2021: $710 · 2022: $181 · 2023: $355 · 2024: $305 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Gift: $87.20 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.28 |
| Gift | $87.20 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $4,718.12 | 2019-2025 | |
| Keystone Dental INC. | $430.96 | 2021 | |
| Nobel Biocare USA | $331.32 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $173.86 | 2024-2025 | Geistlich Bio-Gide, Biomaterials |
| Dentsply Sirona INC | $74.89 | 2024 | Astra Tech Implant System |
| Salvin Dental Specialties, INC. | $50.00 | 2020 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $47.93 | 2023 | |
| Medical Device Business Services, INC. | $43.52 | 2021 | |
| Galderma Laboratories, L.P. | $42.89 | 2021-2024 | |
| Envista Holdings Corporation | $34.48 | 2024 | Spark |
| Allergan, INC. | $16.16 | 2019 | |
| Mentor Worldwide LLC | $13.68 | 2021 | |
| Apyx Medical Corporation | $6.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clement Qaqish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.